Improving the production of platelets from stem cells
Bone Marrow Spatial Transcriptomics to Enhance In Vitro Platelet Production
This study is looking at ways to grow more platelets in the lab from special stem cells to help people who need platelet transfusions, especially those with blood disorders, by making sure the platelets are a good match for them.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston Children's Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10691352 on NIH RePORTER |
What this research studies
This research investigates how to enhance the production of platelets from induced pluripotent stem cells (iPSCs) to address the shortage of donor platelets. By examining the interactions between megakaryocytes, the cells that produce platelets, and the bone marrow environment, the study aims to identify key signaling events that can be replicated in laboratory conditions. The goal is to develop more efficient methods for generating platelets in vitro, which could lead to a sustainable supply for patients in need of transfusions. If successful, this approach could provide personalized and HLA-matched platelets for patients with various blood disorders.
Who could benefit from this research
Good fit: Ideal candidates for this research include patients with blood platelet disorders, those undergoing cancer therapy, or individuals requiring bone marrow transplantation.
Not a fit: Patients with conditions unrelated to platelet production or those who do not require platelet transfusions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly increase the availability of platelets for transfusions, improving treatment outcomes for patients with blood disorders.
How similar studies have performed: Other research has shown promise in using stem cells for platelet production, but this specific approach focusing on the bone marrow environment is relatively novel.
Where this research is happening
Boston, United States
- Boston Children's Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Cantor, Alan B. — Boston Children's Hospital
- Study coordinator: Cantor, Alan B.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.